Metrodent (Gel) Instructions for Use
Marketing Authorization Holder
Kb-Pharma LLC (Republic Of Belarus)
Manufactured By
Synmedic Laboratories Ltd. (India)
ATC Code
A01AB11 (Other drugs)
Active Substances
Chlorhexidine (Rec.INN registered by WHO)
Metronidazole (Rec.INN registered by WHO)
Dosage Forms
| Metrodent | Dental gel 10 mg/g + 0.5 mg/g: 20 g tubes | |
| Dental gel, lemon 10 mg/g + 0.5 mg/g: 20 g tubes | ||
| Dental gel, strawberry 10 mg/g + 0.5 mg/g: 20 g tubes | ||
| Dental gel, pineapple 10 mg/g + 0.5 mg/g: 20 g tubes |
Dosage Form, Packaging, and Composition
Dental gel homogeneous, from colorless to colorless with a slightly yellowish tint, with a specific smell of menthol.
| 1 g | |
| Metronidazole (as benzoate) | 10 mg |
| Chlorhexidine digluconate (20% solution) | 2.5 mg, |
| Which corresponds to the content of chlorhexidine digluconate | 0.5 mg |
Excipients: carbomer 934P – 12 mg, methylparaben – 1 mg, propylparaben – 0.1 mg, propylene glycol – 148.5 mg, sodium saccharin dihydrate – 1 mg, polysorbate 60 – 5 mg, levomenthol – 2.5 mg, trolamine – 5 mg, pineapple or lemon or strawberry flavor – 0.0013 ml, purified water – up to 1 g.
20 g – aluminum tubes (1) – cardboard packs.
Dental gel homogeneous, from colorless to colorless with a slightly yellowish tint, with a specific smell of menthol and a faint smell of lemon.
| 1 g | |
| Metronidazole (as benzoate) | 10 mg |
| Chlorhexidine digluconate (20% solution) | 2.5 mg, |
| Which corresponds to the content of chlorhexidine digluconate | 0.5 mg |
Excipients: carbomer 934P – 12 mg, methylparaben – 1 mg, propylparaben – 0.1 mg, propylene glycol – 148.5 mg, sodium saccharin dihydrate – 1 mg, polysorbate 60 – 5 mg, levomenthol – 2.5 mg, trolamine – 5 mg, pineapple or lemon or strawberry flavor – 0.0013 ml, purified water – up to 1 g.
20 g – aluminum tubes (1) – cardboard packs.
Dental gel homogeneous, from colorless to colorless with a slightly yellowish tint, with a specific smell of menthol and a faint smell of strawberry.
| 1 g | |
| Metronidazole (as benzoate) | 10 mg |
| Chlorhexidine digluconate (20% solution) | 2.5 mg, |
| Which corresponds to the content of chlorhexidine digluconate | 0.5 mg |
Excipients: carbomer 934P – 12 mg, methylparaben – 1 mg, propylparaben – 0.1 mg, propylene glycol – 148.5 mg, sodium saccharin dihydrate – 1 mg, polysorbate 60 – 5 mg, levomenthol – 2.5 mg, trolamine – 5 mg, pineapple or lemon or strawberry flavor – 0.0013 ml, purified water – up to 1 g.
20 g – aluminum tubes (1) – cardboard packs.
Dental gel homogeneous, from colorless to colorless with a slightly yellowish tint, with a specific smell of menthol and a faint smell of pineapple.
| 1 g | |
| Metronidazole (as benzoate) | 10 mg |
| Chlorhexidine digluconate (20% solution) | 2.5 mg, |
| Which corresponds to the content of chlorhexidine digluconate | 0.5 mg |
Excipients: carbomer 934P – 12 mg, methylparaben – 1 mg, propylparaben – 0.1 mg, propylene glycol – 148.5 mg, sodium saccharin dihydrate – 1 mg, polysorbate 60 – 5 mg, levomenthol – 2.5 mg, trolamine – 5 mg, pineapple or lemon or strawberry flavor – 0.0013 ml, purified water – up to 1 g.
20 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Drug with antimicrobial action for topical use in dentistry
Pharmacotherapeutic Group
Antimicrobial agent
Pharmacological Action
Combined antimicrobial drug for topical application.
Metronidazole is a nitroimidazole derivative with antiprotozoal and antibacterial action against anaerobic protozoa and anaerobic bacteria causing periodontitis: Porphyromonas gingivalis, Prevotella intermedia, Prevotella denticola, Fusobacterium fusiformis, Wolinella recta, Treponema spp., Eikenella corrodens, Borrelia vincenti, Bacteroides melaninogenicus, Selenomonas spp.
It is inactive against aerobic bacteria.
The mechanism of action involves the biochemical reduction of the 5-nitro group of metronidazole by intracellular transport proteins of anaerobic microorganisms and protozoa. The reduced 5-nitro group of metronidazole interacts with the DNA of the microorganism cell, inhibiting the synthesis of their nucleic acids, which leads to the death of bacteria.
Chlorhexidine is a disinfectant, active against a wide range of vegetative forms of gram-negative and gram-positive microorganisms, yeasts, dermatophytes and lipophilic viruses. It acts on bacterial spores only at elevated temperatures.
The bactericidal effect is due to the binding of cations (a result of the dissociation of the chlorhexidine salt in a physiological environment) with the negatively charged walls of bacterial cells and extramicrobial complexes. In low concentrations, by disrupting the osmotic balance of bacterial cells and the release of potassium and phosphorus ions from them, it has a bacteriostatic effect; in high concentrations, the cytoplasmic content of the bacterial cell precipitates, which ultimately leads to the death of bacteria.
Indications
Acute gingivitis; acute necrotizing ulcerative gingivitis (Vincent’s gingivitis); chronic edematous gingivitis; chronic hyperplastic gingivitis; chronic atrophic (desquamative) gingivitis; chronic periodontitis; periodontal abscess; recurrent aphthous (ulcerative) stomatitis; gangrenous pulpitis; post-extraction alveolitis; juvenile periodontitis; toothache of infectious origin.
ICD codes
| ICD-10 code | Indication |
| A69.1 | Other Vincent's infections |
| K04 | Diseases of pulp and periapical tissues (including periodontitis) |
| K05 | Gingivitis and periodontal diseases |
| K08.8 | Other specified disorders of teeth and supporting structures (including toothache) |
| K10.3 | Alveolitis of jaws |
| K12 | Stomatitis and related lesions |
| ICD-11 code | Indication |
| 1C4Z | Unspecified bacterial disease |
| DA01.Z | Diseases of the oral mucosa, unspecified |
| DA06.1 | Alveolitis of jaw |
| DA09.Z | Diseases of pulp and periapical tissues, unspecified |
| DA0A.Z | Diseases of teeth and supporting structures, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
| LA30.5Z | Anomalies of tooth resorption or loss, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply topically to the oral cavity only. Use twice daily, typically in the morning and evening, following thorough tooth brushing.
Dry the affected gum area with a gauze pad before application. Apply a thin layer of gel directly to the gingival margin, interdental spaces, and periodontal pockets using a clean finger or a cotton swab.
After application, avoid rinsing the mouth, eating, or drinking for at least 30 minutes to maximize local drug contact time.
The standard treatment course is 7 to 10 days, unless otherwise directed by a dental professional. Do not exceed the recommended duration of use without medical supervision.
For preventive purposes, a small pea-sized amount may be mixed with toothpaste during brushing, but this should not replace the primary therapeutic application method.
In cases of periodontal abscess or post-extraction alveolitis, the gel may be applied directly into the socket or abscess cavity after professional debridement.
If a dose is missed, apply it as soon as remembered. If it is nearly time for the next dose, skip the missed dose and continue with the regular schedule. Do not double the dose.
Discontinue use and consult a dentist if no improvement is observed within 3-5 days, or if symptoms worsen.
Adverse Reactions
Local reactions: “metallic” taste in the mouth.
Systemic reactions: headache, allergic reactions (skin rash, itching, urticaria).
Contraindications
Hypersensitivity (including to metronidazole, chlorhexidine and nitroimidazole derivatives); children under 18 years of age (depending on the dosage form used).
Use in Pregnancy and Lactation
Use during pregnancy is not recommended.
If use during lactation is necessary, the issue of discontinuing breastfeeding should be considered.
Pediatric Use
Contraindication – children under 18 years of age.
Special Precautions
The use of the drug does not replace hygienic brushing of teeth, so during the course of treatment with the drug, tooth brushing should be continued. However, the application of the gel should not be combined with toothpaste at the same time.
Avoid contact with eyes.
Drug Interactions
It enhances the anticoagulant effect of warfarin (increased prothrombin time).
Concomitant use with disulfiram increases toxicity, which may lead to the development of neurological symptoms.
The antimicrobial activity of metronidazole is reduced with simultaneous use with phenobarbital and phenytoin due to accelerated metabolism of metronidazole.
Cimetidine inhibits the metabolism of metronidazole, which may lead to an increase in the concentration of metronidazole in the blood serum.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer